A Cutting-Edge Cancer Treatment May Cause Cancer. The FDA Is Investigating

A Cutting-Edge Cancer Treatment May Cause Cancer. The FDA Is Investigating

4.6
(513)
Write Review
More
$ 28.50
Add to Cart
In stock
Description

CAR-T cell therapy harnesses the immune system to attack blood cancers. Six years after approving the first treatment, the FDA is investigating whether it can give rise to secondary cancers.

8 New FDA-Approved Drugs in May 2023 ⋆ Vial

Vaibhav Bhatia posted on LinkedIn

Is Your Lipstick Full of Lead?

Disparities in Clinical Research and Cancer Treatment

Recent advancements in nanoconstructs for the theranostics applications for triple negative breast cancer - ScienceDirect

media.springernature.com/m685/springer-static/imag

Memorial Sloan Kettering Cancer Center Ranked the Best Cancer Center in the Northeast and First in the Nation for Urology Care by U.S. News & World Report

Cancer experts demand action to end ongoing drug shortage: 'People's lives are really at stake

CRISPR in Cancer Research

Fab Your Unborn Foetus

Diseases, Latest News, Photos & Videos